TIM-3 is highly expressed on tumor infiltrating DCs and actively competes with nucleic acids released from dying tumor cells to bind HMGB1, effectively inhibiting stimulation of the innate immune response by nucleic acids [44]. This evidence concerns the gene HMGB1 and neoplasm.